New Medical Policies

Harvard Pilgrim has developed the following new policies for commercial medical review, and prior authorization is not required:

• Percutaneous Left Atrial Appendage Closure to Reduce Stroke Risk in Patients with Atrial Fibrillation (WatchmanTM Device) Medical Policy
• Fecal Microbial Transplant (FMT) for Clostridium Difficile Infection Medical Policy

Please refer to the respective medical policies for complete details, including coverage criteria, exclusions, required documentation, and coding information.

Publication Information

Audrey Kleinberg,
Director, Provider Relations & Communications

Annmarie Dadoly,
Editor

Joseph O’Riordan,
Writer

Kristin Edmonston,
Production Coordinator